NCT05758051 - Clinical Trial References

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Citation(s)

Li H, Zhao L, Huang L, Kuo KN
Delayed Slipped Capital Femoral Epiphysis After Treatment of Femoral Neck Fracture in Children. Clin Orthop Relat Res. 2015 Aug;473(8):2712-7. doi: 10.1007/s11999-014-4067-y. Epub 2014 Nov 27.
Yerli M, Ocak O, Yuce A, Bayraktar TO, Kir MC, Imren Y, Dedeoglu SS, Gurbuz H
Retrospective analysis of 35 pediatric femoral neck fractures. Eur J Orthop Surg Traumatol. 2022 Oct;32(7):1385-1390. doi: 10.1007/s00590-021-03126-6. Epub 2021 Sep 20.

Management of Slipped Capital Femoral Epiphysis (SCFE) on Top of Fixed Fracture Neck of Femur Case Report.

Clinical trial NCT05758051 - References